<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT2016030126858N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2016-03-22</date_registration>
      <primary_sponsor>Zahedan University of Medical Sciences</primary_sponsor>
      <public_title>The Effect of taking blood from a venipuncture and saline lock on the blood tests</public_title>
      <acronym></acronym>
      <scientific_title>Comparing the effects of two blood taking methods namely, venipuncture and saline lock, on the results of routine blood tests obtained from the CCU hospitalized patients in Ali Ibn Abi Talib Hospital of Zahedan University of Medical Sciences in 2015.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2015-01-26</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>80</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/22152</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: N/A, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Health service research, Other design features: -.</study_design>
      <phase>N/A</phase>
      <hc_freetext>cardiovascular patients.</hc_freetext>
      <i_freetext>Intervention 1: Control group: Taking 5 cc blood from the patient’s opposite hand vein. Intervention 2: Intervention group: Taking 5 cc blood from the patients’ saline lock.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Zahra Piashkarmofrad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Mashahir Square, School of Nursing and Midwifery</address>
        <city>Zahedan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>00989151902115</zip>
        <telephone>+98 54 3341 1415</telephone>
        <email>t.kianian67@gmail.com</email>
        <affiliation>University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>toktam Kianian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nursing and Midwifery</address>
        <city>Zahedan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 54 3341 1515</telephone>
        <email>t.kianian67@gmail.com</email>
        <affiliation>University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria: The patient’s age must range from 35 to 70. They are required to do routine tests of CCU based on the physicians’ order. There should be lack of clinical jaundice and lack of massive hemorrhage such as gastro-intestinal tract bleeding. There should exists Stable hemodynamic status and no sign of pregnancy in female patients. Lack of deformity in both upper limbs (as hemodialysis patients have shunts or Fistula or have mastectomy) is required as well. Exclusion criteria: Hematocrit (less than 25% or more than 60%); Anemia (Hemoglobin less than 12 gm/dl in females and less than 14 gm./dl  in males; Coagulating disorders such as thrombocytopenia; Not having safe and healthy suitable vein for  catheter insertion and Saline lock fixation; Failure  in taking blood from saline lock for first time sampling.</inclusion_criteria>
      <agemin>34 years</agemin>
      <agemax>69 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I20, I21, </hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Angina pectoris, Acute myocardial infarction,  Subsequent myocardial infarction,Certain current complications following acute myocardial infarction, Other acute ischaemic heart diseases, Chronic ischaemic heart disease, Heart failure, Chronic Ischaemic He</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control group: Taking 5 cc blood from the patient’s opposite hand vein</i_keyword>
      <i_keyword>Intervention group: Taking 5 cc blood from the patients’ saline lock</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>BUN. Timepoint: Taking blood from Saline Lock and immediately from vein. Method of measurement: Laboratory experiment.</prim_outcome>
      <prim_outcome>CBC. Timepoint: Taking blood from Saline Lock and immediately from vein. Method of measurement: Laboratory experiment.</prim_outcome>
      <prim_outcome>CRP. Timepoint: Taking blood from Saline Lock and immediately from vein. Method of measurement: Laboratory experiment.</prim_outcome>
      <prim_outcome>ESR. Timepoint: Taking blood from Saline Lock and immediately from vein. Method of measurement: Laboratory experiment.</prim_outcome>
      <prim_outcome>Na. Timepoint: Taking blood from Saline Lock and immediately from vein. Method of measurement: Laboratory experiment.</prim_outcome>
      <prim_outcome>Cr. Timepoint: Taking blood from Saline Lock and immediately from vein. Method of measurement: Laboratory experiment.</prim_outcome>
      <prim_outcome>K. Timepoint: Taking blood from Saline Lock and immediately from vein. Method of measurement: Laboratory experiment.</prim_outcome>
      <prim_outcome>TG. Timepoint: Taking blood from Saline Lock and immediately from vein. Method of measurement: Laboratory experiment.</prim_outcome>
      <prim_outcome>Cholesterol. Timepoint: Taking blood from Saline Lock and immediately from vein. Method of measurement: Laboratory experiment.</prim_outcome>
      <prim_outcome>FBS. Timepoint: Taking blood from Saline Lock and immediately from vein. Method of measurement: Laboratory experiment.</prim_outcome>
      <prim_outcome>CPK. Timepoint: Taking blood from Saline Lock and immediately from vein. Method of measurement: Laboratory experiment.</prim_outcome>
      <prim_outcome>CKmb. Timepoint: Taking blood from Saline Lock and immediately from vein. Method of measurement: Laboratory experiment.</prim_outcome>
      <prim_outcome>LDH. Timepoint: Taking blood from Saline Lock and immediately from vein. Method of measurement: Laboratory experiment.</prim_outcome>
      <prim_outcome>PT. Timepoint: Taking blood from Saline Lock and immediately from vein. Method of measurement: Laboratory experiment.</prim_outcome>
      <prim_outcome>PTT. Timepoint: Taking blood from Saline Lock and immediately from vein. Method of measurement: Laboratory experiment.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>-. Timepoint: -. Method of measurement: -.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id>-</sec_id>
        <issuing_authority>-</issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Zahedan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2014-01-29</approval_date>
        <contact_name>Zahedan University of Medical Sciences</contact_name>
        <contact_address>Mashahir Square, School of Nursing and Midwifery Zahedan  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
